William Wilson

The Royal Melbourne Hospital — Australia

Agricultural and Biological Sciences · Life Sciences

28h-index3.9kcitations231works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Insect and Pesticide Research(70), Plant and animal studies(55), Insect and Arachnid Ecology and Behavior(48), Multiple Myeloma Research and Treatments(27), Knee injuries and reconstruction techniques(26)

Publications230 total

CAR-T cells co-targeting BCMA and CD19 in RRMM: Results from the UKMRA Phase 1 MCARTY trial in relapsed refractory multiple myeloma
Blood·2025
Monitoring and Management of CMV and other Viral Reactivations with Bispecific Antibodies (BsAbs) for Patients with Relapsed and Refractory Multiple Myeloma (RRMM)
Clinical Lymphoma Myeloma & Leukemia·2025
Characteristics and Outcomes of Coronary Artery intervention in Patients With Adult Congenital Heart Disease
Heart Lung and Circulation·2025Open Access
Early Intervention Versus Clinical Surveillance in the Management of Asymptomatic Severe Aortic Stenosis
Heart Lung and Circulation·2025Open Access
Transcatheter Pulmonary Valve Replacement Bioprosthesis Size And Post-Procedural Right Ventricular to Pulmonary Artery Gradients
Heart Lung and Circulation·2025
The Sparta Science force plate is reliable in assessment of recovery following anterior cruciate ligament reconstruction
Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine·2025Open Access
464 | DURABLE RESPONSES AND FAVOURABLE TOXICITY AFTER FAST OFF‐RATE CD19 CAR T‐CELL THERAPY WITH OBECABTAGENE AUTOLEUCEL IN ADULTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES
Hematological Oncology·2025· 1 citedOpen Access
326 | GLOFITAMAB AND EPCORITAMAB FOR LARGE B CELL LYMPHOMA IN 319 REAL WORLD PATIENTS: A RETROSPECTIVE UK ANALYSIS OF EFFICACY, TOLERABILITY AND PRACTICAL IMPLICATIONS
Hematological Oncology·2025Open Access
Clinical outcomes in patients with mismatch repair-deficient colorectal cancer: A retrospective real-world evaluation in a single tertiary cancer centre.
Journal of Clinical Oncology·2025
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial
The Lancet Haematology·2025· 8 citedOpen Access
PERIOPERATIVE RISK OF NON-CARDIAC SURGERY IN PATIENTS WITH AORTIC STENOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Journal of the American College of Cardiology·2025Open Access
IMPACT OF AORTIC STENOSIS IN PATIENTS UNDERGOING HIP FRACTURE SURGERY
Journal of the American College of Cardiology·2025Open Access
Satisfactory patient reported outcomes at five years following primary repair with suture tape augmentation for anterior talofibular ligament injury
The Journal of Foot & Ankle Surgery·2025
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single center, real-world experience
Haematologica·2024· 1 citedOpen Access
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy
British Journal of Cancer·2024· 2 citedOpen Access
Supplementary Data from Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma
2024Open Access
Data from Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma
2024Open Access
Spinal Bracing: A Novel Non-Invasive Technique to Prevent Spinal Fractures and Preserve Spinal Stability in Patients with Multiple Myeloma
Blood·2024· 1 cited
Increased Rates of MRD Conversion from Positive (+ve) to Negative (-ve) Following ASCT Compared to Chemotherapy Consolidation in Newly Diagnosed Multiple Myeloma Is Prognostic for Improved Progression Free Survival: Dynamic MRD Assessment in the UK-MRA Cardamon Trial
Blood·2024Open Access
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications
Blood·2024· 6 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Graeme P. Hopper(9), Gordon M. Mackay(9), Patti J. Elzen(7), Virmarie Correa-Fernández(6), Bryce Kyburz(6), Teresa Williams(6), Lorraine R. Reitzel(6), Cho Y. Lam(5), James R. Baxter(4), Frank A. Eischen(4), Kathryn A. Taubert(3), Michael A. Gerber(3), Patricia Ferrieri(3), Marla Spivak(3), David Westervelt(3), Charlotte Randall(3), Paul A. Byrne(3), Daniel P. O’Connor(3), Joanne M. Jenkins(3), Khurum Khan(3)